Optimal Biological Dose for Molecularly Targeted Therapies

Chul Ahn, Seung Ho Kang, Yang Xie

Research output: Chapter in Book/Report/Conference proceedingChapter

Original languageEnglish (US)
Title of host publicationMethods and Applications of Statistics in Clinical Trials
PublisherWiley Blackwell
Pages496-505
Number of pages10
Volume2
ISBN (Print)9781118596333, 9781118304761
DOIs
StatePublished - Jun 9 2014

Fingerprint

Disease-Free Survival
Therapeutics

Keywords

  • Biological dose
  • Cytotoxic anticancer drug
  • Dose escalation
  • Molecularly targeted therapies
  • Progression-free survival

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Ahn, C., Kang, S. H., & Xie, Y. (2014). Optimal Biological Dose for Molecularly Targeted Therapies. In Methods and Applications of Statistics in Clinical Trials (Vol. 2, pp. 496-505). Wiley Blackwell. https://doi.org/10.1002/9781118596333.ch29

Optimal Biological Dose for Molecularly Targeted Therapies. / Ahn, Chul; Kang, Seung Ho; Xie, Yang.

Methods and Applications of Statistics in Clinical Trials. Vol. 2 Wiley Blackwell, 2014. p. 496-505.

Research output: Chapter in Book/Report/Conference proceedingChapter

Ahn, C, Kang, SH & Xie, Y 2014, Optimal Biological Dose for Molecularly Targeted Therapies. in Methods and Applications of Statistics in Clinical Trials. vol. 2, Wiley Blackwell, pp. 496-505. https://doi.org/10.1002/9781118596333.ch29
Ahn C, Kang SH, Xie Y. Optimal Biological Dose for Molecularly Targeted Therapies. In Methods and Applications of Statistics in Clinical Trials. Vol. 2. Wiley Blackwell. 2014. p. 496-505 https://doi.org/10.1002/9781118596333.ch29
Ahn, Chul ; Kang, Seung Ho ; Xie, Yang. / Optimal Biological Dose for Molecularly Targeted Therapies. Methods and Applications of Statistics in Clinical Trials. Vol. 2 Wiley Blackwell, 2014. pp. 496-505
@inbook{f20bcde527ef4279a4adc7595b0b0d3a,
title = "Optimal Biological Dose for Molecularly Targeted Therapies",
keywords = "Biological dose, Cytotoxic anticancer drug, Dose escalation, Molecularly targeted therapies, Progression-free survival",
author = "Chul Ahn and Kang, {Seung Ho} and Yang Xie",
year = "2014",
month = "6",
day = "9",
doi = "10.1002/9781118596333.ch29",
language = "English (US)",
isbn = "9781118596333",
volume = "2",
pages = "496--505",
booktitle = "Methods and Applications of Statistics in Clinical Trials",
publisher = "Wiley Blackwell",

}

TY - CHAP

T1 - Optimal Biological Dose for Molecularly Targeted Therapies

AU - Ahn, Chul

AU - Kang, Seung Ho

AU - Xie, Yang

PY - 2014/6/9

Y1 - 2014/6/9

KW - Biological dose

KW - Cytotoxic anticancer drug

KW - Dose escalation

KW - Molecularly targeted therapies

KW - Progression-free survival

UR - http://www.scopus.com/inward/record.url?scp=84926400384&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84926400384&partnerID=8YFLogxK

U2 - 10.1002/9781118596333.ch29

DO - 10.1002/9781118596333.ch29

M3 - Chapter

AN - SCOPUS:84926400384

SN - 9781118596333

SN - 9781118304761

VL - 2

SP - 496

EP - 505

BT - Methods and Applications of Statistics in Clinical Trials

PB - Wiley Blackwell

ER -